Abstract
Regeneration of cardiac muscle has been the ultimate objective of cell-based therapy over the last decade. The first generation of clinical stem cell trials in cardiology, however, have borne only modest success, such that the regeneration of mature cardiomyocytes remains elusive ([1][1]). Rather,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have